MedTrace Logo

Assessing of Physicians' Knowledge About International Guidelines of Albumin Use in Patients With Liver Cirrhosis

NCT04242979 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2020-01-27

No results posted yet for this study

Summary

Due to shortage of local studies of the adherence of physicians to the guidelines for albumin use among patients with liver cirrhosis so this study aims to assess:

1. Physicians' knowledge on the evidence-based indications for HA use supported by the international guidelines;
2. Whether HA is used in clinical conditions not supported by solid scientific evidence;
3. To formulate the evidence-based indications for HA use supported by the international guidelines and to evaluate effect of distributing these evidence-based indications on physicians' knowledge.

Conditions

  • Liver Cirrhoses

Interventions

BEHAVIORAL

Questionnaire about albumin use in liver cirrhosis

1. Permission to carry out the study will be obtained from the Faculty's Ethics Committee. 2. To achieve validity and reliability of the tool. It will be reviewed by two experts in the field of the study and necessary modification will be done. 3. A pilot study will be 10% done to test the clarity and feasibility of developed tool. 4. Each participant involved in the study will be assessed for his or her knowledge using (tool I). 5. Data will be collected by personal interview with participants or via fulfilling online questionnaire taking in consideration data confidentiality. 6. Application of the designed evidence based indications for human albumin use supported by the international guidelines will be done by researcher using (tool II). 7. Evaluate the effect of the designed evidence based indications for human albumin use supported by the international guidelines on physicians' knowledge after 1 month using (tool I) in a random sample of those physicians

Sponsors & Collaborators

  • Abdelrahman Salah Eldin Abodief

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
26 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2022-04-01
Completion
2023-04-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242979 on ClinicalTrials.gov